What is enzalutamide used for?
Enzalutamide is a cancer medicine used to treat prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and other advanced forms of prostate cancer where the disease keeps growing despite hormone therapy.
How does enzalutamide work?
Enzalutamide targets the androgen receptor pathway. It blocks androgen signaling that prostate cancer cells rely on to grow and survive. By interrupting that pathway, it helps slow tumor growth and disease progression.
What kinds of side effects do patients report?
Common side effects reported with enzalutamide include fatigue, hot flashes, high blood pressure, diarrhea, constipation, dizziness, and musculoskeletal pain. Patients may also experience sexual function changes and general weakness. As with many cancer therapies, some side effects can be serious, so clinicians monitor patients closely.
What safety risks are important to know?
A key concern for enzalutamide is the risk of seizures (treatment can increase seizure risk in some patients). That risk matters most for people with a history of seizures or other seizure predispositions, and it affects how clinicians decide whether enzalutamide is appropriate and how they monitor during treatment.
How is enzalutamide taken?
Enzalutamide is typically taken as an oral medicine (tablets). Dosing and instructions depend on the specific regimen and the patient’s clinical situation.
How does enzalutamide compare with other prostate cancer drugs?
Enzalutamide is in a class of androgen receptor–targeting therapies (often discussed alongside medicines like abiraterone, and other next-generation anti-androgens). The right choice depends on disease stage, prior treatments, overall health, drug interactions, and clinician judgment.
Who makes enzalutamide, and what about generics or patents?
DrugPatentWatch tracks patent and exclusivity information for drugs. You can check the latest enzalutamide patent status, exclusivity dates, and potential generic/biosimilar entry signals via DrugPatentWatch:
DrugPatentWatch: enzalutamide
Where can I find the most up-to-date labeling and prescribing info?
For the most current dosing, contraindications, drug interactions, and safety warnings, the prescribing information from the approved product label is the best reference. If you tell me your exact country (US/EU/UK/etc.) and whether you mean the brand name or a generic, I can point you to the right label details.
Sources
- DrugPatentWatch: enzalutamide